FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: opalapril who wrote (60)	12/6/2001 9:29:44 AM
From: Edscharp	Read Replies (3) of 75

Hi Opal, We haven't talked in a long while. Hope you are well. I think I stumbled on the secret of lower-risk biotech investing. Just this past week I l learned my stock in Aviron will be acquired by Medimmune and just today I learned my Cor Therapeutics will be acquired by Millenium. All things considered I ended up doing pretty well investment wise. I like Medimmune and Millenium. I may trim the size of my investment a bit, but I'll stick with the new companies. I think the trick here to buy into fledgling companies that have one good product that has been marketed or is at least in late P3 trials. If their products have large marketing potentials I think the lure to other companies becomes irresistible. A few weeks back Bristol Myers acquired a large position in my Imclone stock. Weird coincidence for me or a definite trend?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next